Patients tend to get dehydrated on semaglutide due to slowed digestion, reduced thirst cues, and potential nausea or vomiting
As a result, many patients: Feel satisfied with smaller meals Experience fewer cravings Consume fewer calories naturally Lose weight steadily over time Semaglutide is the active ingredient in medications such as: Wegovy Ozempic (approved for Type 2 diabetes) Rybelsus (oral formulation) For many Tampa patients, semaglutide serves as an excellent starting point for medically supervised weight loss
Synergistic effects are observed in combination therapy: Mdivi-1 (Drp1 inhibitor, 10 M) combined with resveratrol (25 M) coordinately regulates mitochondrial dynamics (inhibiting fission, promoting fusion) and biogenesis, reducing MMP13 expression by 68% in vitro and alleviating cartilage erosion in OA rats more significantly than monotherapy (11, 94)
Weight loss, improved blood-sugar control and better metabolic health can lead to increased energy and improved self-esteem, which may help reduce depressive symptoms
Start with a lower probiotic dose and increase gradually to reduce the risk of bloating or gas, which can otherwise be hard to distinguish from nausea caused by semaglutide or liraglutide